Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
about
Site-directed mutagenesis identifies residues involved in ligand recognition in the human A2a adenosine receptorHydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition"Cleavable trifunctional" approach to receptor affinity labeling: chemical regeneration of binding to A1-adenosine receptorsMolecular probes for muscarinic receptors: functionalized congeners of selective muscarinic antagonistsStructure-Based Design of Reactive Nucleosides for Site-Specific Modification of the A2A Adenosine Receptor8-(3-Isothiocyanatostyryl)caffeine Is a Selective, Irreversible Inhibitor of Striatal A(2)-Adenosine ReceptorsCovalent binding of a selective agonist irreversibly activates guinea pig coronary artery A2 adenosine receptors.Molecular Characterization of A(1) and A(2a) Adenosine Receptors.Modelling the P2Y purinoceptor using rhodopsin as templateHigh affinity acylating antagonists for muscarinic receptorsAdenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.Solubilized rabbit striatal A2a-adenosine receptors: stability and antagonist binding2-[2-[4-[2-[2-[ 1,3-Dihydro- 1,1-bis (4-hydroxyphenyl)-3-oxo-5-isobenzofuranthioureidyl]ethylaminocarbonyl]ethyl]phenyl] ethylamino]-5'-N-ethylcarboxamidoadenosine (FITC-APEC): A Fluorescent Ligand For A2a-Adenosine Receptors.Application of the functionalized congener approach to dendrimer-based signaling agents acting through A(2A) adenosine receptors.Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusionMolecular modeling of adenosine receptors. I. The ligand binding site on the A1 receptor.
P2860
Q24612312-33EAB605-C035-498B-BBC3-0EDD9677840EQ28115233-0E36F474-44A7-4518-9F54-A8D681EA1AD5Q28367925-72960EA0-F690-4AB4-82F9-2B6B90F345A0Q33585410-CEA3BEAF-FD75-47F6-ADEB-B27ABC253376Q34162656-28300A9A-EBD5-46D5-A504-61DCE6BF36C3Q36083177-8B8BAE9F-626B-4D56-9F1A-CC3784A96032Q36219741-74692641-5017-4426-A477-8B4FA6D4DA85Q36246995-B8D40FFB-162E-43B2-B328-635627846ED5Q36251014-D9894CAF-A0E6-43F2-9E31-A642C62C7C90Q36311698-FEBD2B68-C11B-4834-A060-0555EC950A4BQ36332205-794FAF67-F332-44C5-9139-678A4AD05DE9Q36785568-00D79B65-9626-4FF5-9D86-856700847DD5Q36928619-C16F6415-4151-42A1-B13E-BD9BEF6448AFQ37291594-DA3FE698-AC79-4364-A1B3-89D2140738F9Q37312196-B8DB1F12-39D8-48D7-B6FE-AADE6063CA95Q42161388-FF2EA8CD-30F3-4A1F-BAC2-26FC2E8587DD
P2860
Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
@ast
Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
@en
type
label
Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
@ast
Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
@en
prefLabel
Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
@ast
Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
@en
P2093
P2860
P1476
Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
@en
P2093
P2860
P304
P577
1992-07-01T00:00:00Z